menu
    • menu

    Company profile for XGen Pharmaceuticals

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XGen Pharmaceuticals DJB, Inc. is closely monitoring the status of the COVID-19 outbreak and its impact locally and globally. We are committed to keeping our employees and business partners safe. We are implementing our Crisis Management Plan, and we have a Business Continuity Plan to sustain operations should a quarantine or lockdown situation be put into effect. As part of our Crisis Management Plan, we are doing the followi...
    XGen Pharmaceuticals DJB, Inc. is closely monitoring the status of the COVID-19 outbreak and its impact locally and globally. We are committed to keeping our employees and business partners safe. We are implementing our Crisis Management Plan, and we have a Business Continuity Plan to sustain operations should a quarantine or lockdown situation be put into effect. As part of our Crisis Management Plan, we are doing the following: Adhering to health and safety standards, Postponing non-essential travel etc

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XGen PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    300 Daniel Zenker Drive Horseheads, NY 14845
    Telephone
    Telephone
    +1 866.390-4411
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://xgenpharmadjb.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XGen Pharm`s Generics Nelarabine Receives Approval in US
    XGen Pharm`s Generics Nelarabine Receives Approval in US

    05 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216510

    FDA
    05 Sep 2024
    Share Share
    Xgen Pharms' Generic Pentamidine Isethionate Receives Approval in the U.S.
    Xgen Pharms' Generic Pentamidine Isethionate Receives Approval in the U.S.

    17 Mar 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206982

    FDA
    17 Mar 2022
    Share Share
    Enforcement Report - Week of August 16, 2017
    Enforcement Report - Week of August 16, 2017

    16 Aug 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf

    FDA
    16 Aug 2017
    Share Share
    Enforcement Report - Week of April 12, 2017
    Enforcement Report - Week of April 12, 2017

    12 Apr 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf

    FDA
    12 Apr 2017
    Share Share
    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection
    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection

    08 Feb 2017

    // FDA

    http://www.fda.gov/Safety/Recalls/ucm540769.htm

    FDA
    08 Feb 2017
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search